Product Name | MF | CAS | Details |
---|
Sodium Erythorbate | C6H9NaO6 | 7378-23-6 | Details |
Methyl 6‐methylnicotinate | C8H9NO2 | 5470-70-2 | Details |
6,6-Dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione | C8H10O4 | 5617-70-9 | Details |
Di-tert-butylphosphate potassium salt | C8H18KO4P | 33494-80-3 | Details |
6-Methyl-3-pyridinecarboxaldehyde | C7H7NO2 | 65873-72-5 | Details |
2-Quinolinecarboxaldehyde | C10H7NO | 5470-96-2 | Details |
Di-tert-butyl chloromethyl phosphate | C9H20ClO4P | 229625-50-7 | Details |
Astaxanthin | C40H52O4 | 472-61-7 | Details |
Melatonin | C13H16N2O2 | 73-31-4 | Details |
7-Hydroxy-6-Methoxycumarine | C10H8O4 | 92-61-5 | Details |
Zeaxanthin | C40H56O2 | 144-68-3 | Details |
Harmine | C13H12N2O | 442-51-3 | Details |
5-HTP | C11H12N2O3 | 56-69-9 | Details |
Pterostilbene | C16H16O3 | 537-42-8 | Details |
Piperlorgumia | C17H19NO5 | 20069-09-4 | Details |
Sinapic Acid | C11H12O5 | 7362-37-0 | Details |
Diglycolic Acid | C4H6O5 | 110-99-6 | Details |
Diglycolic Anhydride | C4H4O4 | 4480-83-5 | Details |
Pyridoxine hydrochloride | C8H12ClNO3 | 58-56-0 | Details |
Syringaldazine | C18H20N2O6 | 14414-32-5 | Details |
Pyridine-N-oxide | C5H5NO | 694-59-7 | Details |
6-nitro-2,3-dihydrobenzo[b][1,4]dioxine | C8H7NO4 | 16498-20-7 | Details |
Syringaldehyde | C9H10O4 | 134-96-3 | Details |
6-methyl-1,2,3,4-tetrahydroquinoline | C10H13N | 91-61-2 | Details |
1,1-Cyclopropanedicarboxylic Acid | C5H6O4 | 598-10-7 | Details |
4-Pyridinialdoxime | C6H6N2O | 696-54-8 | Details |
Serotonin Hydrochloride | C10H13ClN2O | 153-98-0 | Details |
Piceatannol | C14H12O4 | 10083-24-6 | Details |
Carfilzomib(For R & D only) | C40H57N5O7 | 868540-17-4 | Details |
Semaglutide | C187H291N45O59 | 910463-68-2 | Details |
Liraglutide | C172H265N43O51 | 204656-20-2 | Details |
Fulvestrant | C32H47F5O3S | 129453-61-8 | Details |
Sodium gluconate | C6H13NaO7 | 527-07-1 | Details |
Inositol | C6H12O6 | 87-89-8 | Details |
AMPPD | C18H23O7P | 122341-56-4 | Details |
NSP-SA | C28H28N2O8S2 | 211106-69-3 | Details |
Vitamin K2 (MENAQUINONE MK-7) | C31H40O2 | 11032-49-8 | Details |
APS-5 | C21H18ClNNaO4PS | 193884-53-6 | Details |
L-malic acid | C4H6O5 | 97-67-6 | Details |
D-Ribose | C5H10O5 | 50-69-1 | Details |
(phen)PPh3CuCF3 | C31H23CuF3N2P | 1334890-93-5 | Details |
Ru(OAc)2((R)-DTB-MeOBIPHEP) | C74H104O6P2Ru | 194497-14-8 | Details |
Pd(η3-C3H5)(COD)]BF4 | C11H10BF4Pd | 32915-11-0 | Details |
((R,R)-2-Amino-1,2-diphenylethyl)[(4-tolyl)sulfonyl]amido](chloro)pentamethylcyclopentadienylrhodium(I) | C32H45ClN2O2RhS | 223392-99-2 | Details |
Ru(OAc)2((S)-DTB-MeOBIPHEP) | C74H104O6P2Ru | 167781-45-5 | Details |
rel-(3R,5S)-1-[2'-[Bis(tricyclo[3.3.1.13,7]dec-1-yl)phosphino-κP]-6-methoxy-5'-(trifluoromethyl)[1,1'-biphenyl]-3-yl]-3,5-dimethylpiperidine]chlorogold | C41H54AuClF3NOP | 1614231-13-8 | Details |
(1,2,5,6-η)-1,5-Cyclooctadiene][(2,3,4,5-η)-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-one]nickel, Ni(COD)CPDH | C37H28NiO | 109799-61-3 | Details |
(1,2,5,6-η)-1,5-Cyclooctadiene][2,3,4,5-tetraphenyl-1-oxide-thiophene]nickel, Ni(COD)TOH | C36H28NiOS | 2764746-16-7 | Details |
(CyPAd-Dalphos)NiCl(otol) | C35H51ClNiO3P2 | 2115838-60-1 | Details |
Ranibizumab | C11H12N2O2 | 347396-82-1 | Details |
(R)-(-)-t-Butylmethyl(di-t-butylphosphinomethyl)phosphino(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate,97% (R)-TCFP-Rh | C22H42P2 | 705945-70-6 | Details |
(Acetylacetonato)(norbornadiene)rhodium(I) | C12H15O2Rh | 32354-50-0 | Details |
(S)-(+)-t-Butylmethyl(di-t-butylphosphinomethyl)phosphino(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate,97% (S)-TCFP-Rh | C22H42BF4P2Rh | 705945-68-2 | Details |
(Bicyclo[2.2.1]hepta-2,5-diene)[1,4-bis(diphenylphosphino)butane]rhodium(I) tetrafluoroborate | C35H36BF4P2Rh | 82499-43-2 | Details |
(1,5-cyclooctadiene)platium(II) bis(trifluromethylsulfonate) | C10H8F6O6PtS2 | 353796-98-2 | Details |
(1,5-Cyclooctadiene)bis(triphenylphosphine)rhodium(I) hexafluorophosphate dichloromethane complex (1:1) | C45H44Cl2F6P3Rh4* | 35238-97-2 | Details |
(R,R)-Ph-BPE-Rh(acac),97% | C39H45O2P2Rh | 869487-30-9 | Details |
(+)-Dichloro[(4R)-4-(i-propyl)-2-{(R)-2-(diphenylphosphino)ferrocenyl}oxazoline](triphenylphosphine)ruthenium(II) | C46H43Cl2FeNOP2Ru10* | 849921-25-1 | Details |
(S)-XylBINAP-Rh(Acac) | C57H57O2P2Rh | 2408796-52-9 | Details |
(1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride | C36H52AlClN2O2 | 307926-51-8 | Details |
(4R,5R)-(-)-2,2-Dimethyl-α,α,α',α'-tetraphenyl-1,3-dioxolane-4,5-dimethanolato[1,2-bis(dimethoxy)ethane]titanium(IV) dichloride | C31H30Cl2O4Ti.C4H10O2.C2H3N | 328123-04-2 | Details |
1,2-Bis(dicyclohexylphosphino)ethane]palladium(II)chloride,95% | C26H48Cl2P2Pd | 96165-44-5 | Details |
(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride | C36H52AlClN2O2 | 250611-13-3 | Details |
2,6-Bis[(di-1-piperidinylphosphino)amino]phenyl]palladium(II) chloride,98% | C26H45ClN6P2Pd | 955035-37-7 | Details |
(1,5-Cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) hexafluorophosphate, [Ir(COD)(PPh2Me)2]PF6 | C34H38F6IrP3 | 38465-86-0 | Details |
((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl] (diphenylphosphinite)(1,5-COD)iridium(I) te | C37H34NO3P.C32H12BF24.C8H12.Ir | 880262-16-8 | Details |
((4S,5S)-(-)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl]-dicyclohexylphosphinite)(1,5-COD)iridium(I) | C77H67BF24IrNO2P | 583844-38-6 | Details |
((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl] (dicyclohexylphosphinite)(1,5-COD)iridium(I | C77H67BF24IrNO2P | 880262-14-6 | Details |
(Dimethylphenylphosphine)gold chloride | C8H12AuClP | 28978-09-8 | Details |
(Dimethylsulfide)gole(I)chloride, (CH3SCH3)AuCl | C2H7AuClS | 29892-37-3 | Details |
(1,10-Phenanthroline)bis(triphenylphosphine)copper(I) nitrate dichloromethane adduct | C48H40CuN3O3P2 | 33989-10-5 | Details |
(Acetonitrile)[(2-biphenyl)di-tert-butylphosphine]gold(I) hexafluoroantimonate | C22H30AuF6NPSb | 866641-66-9 | Details |
(2,2′-Bipyridine)dichloropalladium(II) | C10H8Cl2N2Pd | 14871-92-2 | Details |
(-)-Dichloro[(4S)-4-(i-propyl)-2-{(S)-2-(diphenylphosphino)ferrocenyl}oxazoline](triphenylphosphine)ruthenium(II) | C46H43Cl2FeNOP2Ru10* | 212133-11-4 | Details |
(6Z)-6-[(tert-butylamino)methylidene]cyclohexa-2,4-dien-1-one,Cu(TBS)2 | C22H28CuN2O2 | 13986-34-0 | Details |
RuCl(p-cymene)((S)-binap)]Cl | C54H44Cl2P2Ru | 130004-33-0 | Details |
Pd(IPr)(3-Cl-pyridine)Cl2].0.4CuI | Details |
RuCl(p-cymene)((R)-binap)]Cl | C54H44Cl2P2Ru | 145926-28-9 | Details |
P,P'-1,3-Bis(di-i-propylphosphino)propane][P-1,3-bis(di-i-propylphosphino)propane]palladium (0),98% | C30H68P4Pd | 123333-45-9 | Details |
(R-BINAP)RuCl2 | C44H32Cl2P2Ru | 132071-87-5 | Details |
(T-4)-[(1R)-(1,1-Dimethylethyl)methylphosphine]trihydroboron | C5H16BP | 263768-77-0 | Details |
(S)-N,N-dimethyl-1-((R)-2-Diphenylphosphino)ferrocenylethylamine | C26H22FeNP | 137695-36-4 | Details |
(+)-6,6'-{[(1R,3R)-1,3-Dimethyl-1,3-propanediyl]bis(oxy)}bis[4,8-bis(t-butyl)-2,10-dimethoxy-bibenzo[d,f][1,3,2]dioxaphosphepin], (R,R)-Chiraphite | C49H66O10P2 | 149646-83-3 | Details |
(3aS,3'aS,8aR,8'a'R)-2,2'-Cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole | C23H20N2O2 | 182122-08-3 | Details |
(3aR,3'aR,8aS,8'a'S)-2,2'-Cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole | C23H20N2O2 | 229184-98-9 | Details |
(S)-2-(Diphenylphosphino)-1-phenylethanaminium tetrafluoroborate,97% | Details |
(S)-1-[2-(Diphenylphosphino)phenyl]ethanaminium tetrafluoroborate,97% | Details |
(S)-1-(Diphenylphosphino)-3-methylbutan-2-aminium tetrafluoroborate,97% | Details |
(S)-1-(Diphenylphosphino)-3,3-dimethylbutan-2-aminium tetrafluoroborate,97% | Details |
(1R,2R)-2-(Diphenylphosphino)cyclohexanaminium tetrafluoroborate,97% | Details |
(1R,2R)-2-[(4S,11bR)-3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]-1-phenylpropan-2-amine, min. 97% | C31H28NP | Details |
(R)-1-(Diphenylphosphino)-3-methylbutan-2-aminium tetrafluoroborate,97% | Details |
(1R,2R)-2-[(4S,11bR)-3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]-1,2-diphenylethanamine, min. 97% | C36H30NP | 1469882-57-2 | Details |
(R)-1-(Diphenylphosphino)-3,3-dimethylbutan-2-aminium tetrafluoroborate,97% | Details |
(1S,2S)-2-(Diphenylphosphino)cyclohexanaminium tetrafluoroborate,97% | Details |
(1R,2R)-2-[(4S,11bR)-3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]-1-phenylpropan-2-aminium tetrafluorborate,97% | Details |
((2,4,6-Tri-isopropyl)phenyl)di-cyclohexylphosphine,97% | C27H45P | 303111-96-8 | Details |
(R)-(-)-4-Chlorodinaphthol[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,95% | C20H12ClO2P | 155613-52-8 | Details |
(S)-1-(Diphenylphosphino)-2-amino-3-methylbutane, min. 97% | C17H22NP | 146476-37-1 | Details |
Product Total: Product Page: | ||||
54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 |